About Ondek

About company

The company is developing an oral therapeutic candidate, ImmBALANCE®, derived from H. pylori, to treat paediatric allergy – which frequently manifests initially as atopic dermatitis (also known as eczema) and may progress to include food allergies, allergic asthma, allergic rhinitis and other allergic conditions.